CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes | −4,716 | $483.28 | $2.3M | 70,006 |
| 2025-02-24 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −828 | $483.28 | $400K | 9,970 |
| 2025-02-24 | ALTSHULER DAVID EVP, Chief Scientific Officer | Shares withheld for taxes 10b5-1 | −3,971 | $483.28 | $1.9M | 41,048 |
| 2025-02-20 | ALTSHULER DAVID EVP, Chief Scientific Officer | Sale 10b5-1 | −1,111 | $480.00 | $533K | 45,019 |
| 2025-02-18 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −244 | $455.06 | $111K | 67,695 |
| 2025-02-18 | Biller Jonathan EVP and Chief Legal Officer | Sale 10b5-1 | −1,657 | $455.06 | $754K | 17,606 |
| 2025-02-18 | Ambrose Kristen SVP & Chief Accounting Officer | Sale 10b5-1 | −671 | $455.06 | $305K | 10,798 |
| 2025-02-14 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Shares withheld for taxes | −2,293 | $463.46 | $1.1M | 63,241 |
| 2025-02-14 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Shares withheld for taxes 10b5-1 | −2,293 | $463.46 | $1.1M | 67,939 |
| 2025-02-14 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes | −2,139 | $463.46 | $991K | 74,663 |
| 2025-02-14 | LEIDEN JEFFREY M Executive Chairman | Shares withheld for taxes | −6,066 | $463.46 | $2.8M | 24,026 |
| 2025-02-14 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −6,553 | $463.46 | $3.0M | 129,380 |
| 2025-02-14 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −1,912 | $463.46 | $886K | 40,941 |
| 2025-02-14 | Biller Jonathan EVP and Chief Legal Officer | Shares withheld for taxes 10b5-1 | −1,504 | $463.46 | $697K | 19,263 |
| 2025-02-14 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes | −1,529 | $463.46 | $709K | 27,907 |
| 2025-02-14 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes | −2,724 | $463.46 | $1.3M | 74,722 |
| 2025-02-14 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −564 | $463.46 | $261K | 11,469 |
| 2025-02-14 | ALTSHULER DAVID EVP, Chief Scientific Officer | Shares withheld for taxes | −2,293 | $463.46 | $1.1M | 46,130 |
| 2025-02-13 | LEIDEN JEFFREY M Executive Chairman | Shares withheld for taxes | −2,525 | $450.83 | $1.1M | 30,092 |
| 2025-02-12 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Grant or award | +6,655 | 65,534 |
Page 15 of 18 · 344 trades